Cotinga Pharmaceuticals (Cotinga Pharmaceuticals) Days Sales Outstanding : 0.00 (As of Jan. 2020)

View and export this data going back to 2007. Start your Free Trial

What is Cotinga Pharmaceuticals Days Sales Outstanding?

Cotinga Pharmaceuticals's average Accounts Receivable for the three months ended in Jan. 2020 was $0.00 Mil. Cotinga Pharmaceuticals's Revenue for the three months ended in Jan. 2020 was $0.00 Mil.

The historical rank and industry rank for Cotinga Pharmaceuticals's Days Sales Outstanding or its related term are showing as below:

COTQF's Days Sales Outstanding is not ranked ^*
in the Biotechnology industry.
Industry Median: 72.67
* Ranked among companies with meaningful Days Sales Outstanding only.

Cotinga Pharmaceuticals's Days Sales Outstanding stayed the same from Jan. 2019 (0.00) to Jan. 2020 (0.00).

Cotinga Pharmaceuticals Days Sales Outstanding Historical Data

The historical data trend for Cotinga Pharmaceuticals's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cotinga Pharmaceuticals Days Sales Outstanding Chart

Cotinga Pharmaceuticals Annual Data

Trend

Apr10

Apr11

Apr12

Apr13

Apr14

Apr15

Apr16

Apr17

Apr18

Apr19

Days Sales Outstanding

Get a 7-Day Free Trial

Cotinga Pharmaceuticals Quarterly Data
	Apr15	Jul15	Oct15	Jan16	Apr16	Jul16	Oct16	Jan17	Apr17	Jul17	Oct17	Jan18	Apr18	Jul18	Oct18	Jan19	Apr19	Jul19	Oct19	Jan20
Days Sales Outstanding	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Cotinga Pharmaceuticals's Days Sales Outstanding

For the Biotechnology subindustry, Cotinga Pharmaceuticals's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cotinga Pharmaceuticals's Days Sales Outstanding Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Cotinga Pharmaceuticals's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Cotinga Pharmaceuticals's Days Sales Outstanding falls into.

Cotinga Pharmaceuticals Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Cotinga Pharmaceuticals's Days Sales Outstanding for the fiscal year that ended in Apr. 2019 is calculated as

	Days Sales Outstanding (A: Apr. 2019 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Apr. 2018 )	+	Accounts Receivable (A: Apr. 2019 ))	/	count )	/	Revenue (A: Apr. 2019 )	*	Days in Period
=	( (0	+	0)	/	1 )	/	0	*	365
=	0					/	0	*	365
=	N/A

Cotinga Pharmaceuticals's Days Sales Outstanding for the quarter that ended in Jan. 2020 is calculated as:

	Days Sales Outstanding (Q: Jan. 2020 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Oct. 2019 )	+	Accounts Receivable (A: Jan. 2020 ))	/	count )	/	Revenue (A: Jan. 2020 )	*	Days in Period
=	( (0	+	0)	/	1 )	/	0	*	365 / 4
=	0					/	0	*	365 / 4
=	N/A

Cotinga Pharmaceuticals (OTCPK:COTQF) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Cotinga Pharmaceuticals Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Cotinga Pharmaceuticals's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Cotinga Pharmaceuticals (Cotinga Pharmaceuticals) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cotinga Pharmaceuticals Inc (OTCPK:COTQF) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

N/A

Address

82 Richmond Street East, The Canadian Venture Building, Toronto, ON, CAN, M5C1P1

Website

http://www.cotingapharma.com

Cotinga Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company's lead clinical candidate, COTI-2, is an oral small molecule targeting p53, a tumor suppressor gene that is mutated in over 50% of all cancers, and the company's second clinical candidate, COTI-219, is a novel oral small molecule compound targeting the mutant forms of KRAS with such mutations occurring in up to 30% of all cancers.

Cotinga Pharmaceuticals (Cotinga Pharmaceuticals) Headlines

From GuruFocus

Cotinga Pharmacueticals Announces Closing of Unit Offering

By GlobeNewswire GlobeNewswire • 05-22-2019

Cotinga Pharmaceuticals Reports Fiscal 2018 Third Quarter Financial and Operating Results

By GlobeNewswire GlobeNewswire • 04-03-2018